Omar Ali
Pediatric Endocrinology · Madera, CANPI 1568402188
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 190 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 22.6% — the pattern of someone who eats at a lot of different presentations.
Across 190 payments — averaging $26.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Abbott$515
- Dexcom, Inc.$411
- Tandem Diabetes Care, Inc.$293
- Sanofi-aventis U.S. LLC$286
- Ascendis Pharma Endocrinology Inc$284
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,071100%
- Education$240%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 52 | $1,151 |
| Abbott | 18 | $515 |
| Dexcom, Inc. | 9 | $411 |
| Tandem Diabetes Care, Inc. | 10 | $293 |
| Sanofi-aventis U.S. LLC | 5 | $286 |
| Ascendis Pharma Endocrinology Inc | 8 | $284 |
| Novo Nordisk | 12 | $264 |
| Tolmar, Inc. | 7 | $181 |
| Ultragenyx Pharmaceutical Inc. | 10 | $180 |
| Pfizer | 8 | $178 |
| Medtronic | 6 | $155 |
| Insulet Corporation | 5 | $153 |
| AstraZeneca(2 entities) | 2 | $123 |
| Xeris Pharmaceuticals, Inc. | 6 | $109 |
| Rhythm Pharmaceuticals, Inc. | 4 | $100 |
| Kyowa Kirin, Inc. | 4 | $84 |
| Biomarin Pharmaceutical Inc. | 1 | $80 |
| Johnson & Johnson | 1 | $73 |
| Ipsen Biopharmaceuticals, Inc | 3 | $67 |
| Soleno Therapeutics, Inc. | 2 | $64 |
| Vistapharm, Inc. | 3 | $64 |
| Azurity Pharmaceuticals, Inc. | 3 | $62 |
| Neurocrine Biosciences, Inc. | 2 | $41 |
| Lilly USA, LLC | 2 | $37 |
| Arbor Pharmaceuticals, Inc. | 2 | $34 |
| Avita Medical Americas, LLC | 1 | $29 |
| Tolmar Pharmaceuticals, Inc. | 1 | $24 |
| Endo Pharmaceuticals Inc. | 1 | $21 |
| Lifescan, Inc. | 1 | $18 |
| GSK | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lupron Depot$475
- DEXCOM G6 TRANSMITTER$296
- FREESTYLE LIBRE 3$147
- SKYTROFA$123
- TZIELD$122
- FreeStyle Libre 2$111
- t-slim insulin pump$111
- FARXIGA$110
How this compares
$5,095 in reported general payments places this provider in the 75th percentile of 168 pediatric endocrinology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 12 | $59 |
Paid to pharmacies, not to this prescriber.
Other pediatric endocrinology in Madera
- Jarreau Spencer ChenMadera$5K
- Meenal MendirattaMadera$3K
- Gnanagurdasan PrakasamSacramento$805K
- Swati ElchuriVentura$210K
- Karen KleinSan Diego$195K
- Francine KaufmanLos Angeles$184K
- Lynda PolgreenOrange$167K
- Kevin KaisermanWest Covina$150K
- Amrit BhangooLong Beach$140K
- Mitchell GeffnerLos Angeles$129K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.